Addressing Gaps in Cardiovascular Health
Cardiovascular disease is one of the most significant public health issues in the world. Our commitment to cardiovascular disease remains steadfast, and supporting cross-sector collaborative programs and patient-advocacy initiatives is part of this commitment. A key focus of this work is moving from a reactive healthcare model toward a proactive and innovative public health approach aimed to predict and prevent the impact of serious diseases from occurring. Together, we are employing and testing not just one approach but a range of innovative initiatives to help improve patient outcomes and address population health.
Check. Change. Control. Cholesterol™
Amgen has partnered with American Heart Association on Check. Change. Control. Cholesterol™ program, which aims to reduce the number of Americans who have heart attacks and strokes by improving cholesterol management of high-risk cardiovascular disease patients through a multifaceted approach.
See the Program
Amgen has partnered with American College of Cardiology (ACC) on TRANSFORM: ACS, a program that aims to initiate lipid-lowering treatment closer to hospital discharge for ACS patients.
View Press Release
Alliance for the Million Hearts®
Amgen is part of the CDC Foundation’s Alliance for the Million Hearts campaign, an initiative focused on changing the way people think about and embrace CVD prevention — promoting simple and sustained steps that people can take to help protect their heart health.
Read the Article